DuoGenic StemCells Corp.

DuoGenic StemCells Corp. is a healthcare company specializing in the development and provision of advanced cell therapy products and stem cell culture technologies. Founded in 2018 and based in Taichung City, Taiwan, the company’s core activities include the production of high-quality, xeno-free, and certified stem cell culture media suitable for both research and clinical applications. DuoGenic StemCells Corp. also manufactures cell separator sets, which are used in the extraction and purification of peripheral blood cells, supporting therapies for degenerative diseases such as osteoarthritis. Its portfolio encompasses mesenchymal and endothelial stem cell culture media, recombinant proteins, and closed system cell separation devices. The company has achieved notable regulatory certifications including GMP and ISO 13485, underpinning its commitment to quality and safety. In the broader financial market, DuoGenic StemCells Corp. represents the innovative healthcare and biotechnology segment, contributing to the advancement of regenerative medicine and cell-based therapies in Taiwan, Asia, and North America.